Immunome develops targeted cancer treatments, specifically focusing on antibody-drug conjugates and radioligand therapies for solid tumors. The company is currently testing several drug candidates in clinical trials to treat conditions like desmoid tumors and other cancers. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?
